STARR CHRISTOPHER M sold MNPR
October 1, 2026 · Form 4 insider transaction
STARR CHRISTOPHER M sold 799 shares of Monopar Therapeutics Inc. at $79.67 per share, a transaction worth $63.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on May 28, 2026.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.50 to $80.01, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (6) to this Form 4.